本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

NovoCure Limited

16.49
-0.4900-2.89%
盤後16.510.0200+0.12%18:12 EDT
成交量:98.54萬
成交額:1,609.61萬
市值:18.13億
市盈率:-10.55
高:16.80
開:16.25
低:15.92
收:16.98
資料載入中...

公司資料

公司名字:
NovoCure Limited
交易所:
NASDAQ
成立時間:
2000
員工人數:
1488
公司地址:
Neuhofstrasse 21,Baar,Zug,Switzerland
郵編:
6340
電話:
- -
傳真:
- -
簡介:
Novocure Limited是一家公共有限責任公司,於2000年2月11日在澤西島海峽群島法律下註冊成立。該公司是一家商用的抗腫瘤公司,開發了一種新的專有的療法被稱為腫瘤治療領域,或TTFields,用來對抗實體瘤癌症。

董事

名稱
職位
Asaf Danziger
President, Chief Executive Officer and Director
Kinyip Gabriel Leung
Director and Vice Chairman of the Board
William F. Doyle
Director and Executive Chairman
Yoram Palti
Director and Chief Technology Officer
Charles G. Phillips III
Director
Gert Lennart Perlhagen
Director
Louis J. Lavigne, Jr.
Director
Martin J. Madden
Director
William A. Vernon
Director
William Burkoth
Director

股東

名稱
職位
Asaf Danziger
President, Chief Executive Officer and Director
Michael J. Ambrogi
Chief Operating Officer
Wilhelmus Groenhuysen
Chief Financial Officer
Eilon Kirson
Chief Science Officer and Head of Research and Development
Todd Longsworth
General Counsel
William F. Doyle
Director and Executive Chairman
Yoram Palti
Director and Chief Technology Officer